Loading…
Loading…
WST · NYSE · Healthcare
“At 34.8 times earnings, West Pharmaceutical's valuation demands exceptional growth sustainability that prudent investors should scrutinize against demonstrated intrinsic worth.”
— In the voice of Graham
Year-to-date total return including price appreciation. Compare performance against the S&P 500 benchmark.
Market Cap
$17.19B
P/E Ratio
34.83
Forward P/E
—
EPS
$6.83
PEG Ratio
15.59
Book Value
$43.93
Dividend Yield
0.35%
Profit Margin
16.06%
ROE
15.54%
Use the interactive ytd return with pre-loaded data for West Pharmaceutical Services Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for WST: